The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global medical device outsourcing market was valued at US$ 105.6 Billion in 2021.
We expect the global medical device outsourcing market to exhibit a CAGR of 9.10% during 2022-2027.
The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of medical device outsourcing for package testing validation and sterilization validation of the antigen testing kits for the coronavirus infection.
The increasing demand for medical device outsourcing services over traditional approaches, as they offer enhances efficiency, improves product quality, minimized business risks, etc., is primarily driving the global medical device outsourcing market.
Based on the service, the global medical device outsourcing market can be categorized into regulatory consulting, product design and development, product testing and sterilization, product implementation, product upgrade, and product maintenance. Currently, product design and development exhibits clear dominance in the market.
Based on the therapeutics, the global medical device outsourcing market has been segmented into cardiology, diagnostic imaging, orthopedic, IVD, ophthalmic, general and plastic surgery, drug delivery, dental, endoscopy, and diabetes care. Among these, cardiology currently holds the largest market share.
Based on the application, the global medical device outsourcing market can be bifurcated into class I, class II, and class III. Currently, class II accounts for the majority of the total market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where Asia-Pacific currently dominates the global market.
Some of the major players in the global medical device outsourcing market include Celestica Inc. (Onex Corporation), Charles River Laboratories International Inc., Flex Ltd., Freyr Inc., Heraeus Holding GmbH, ICON plc, Integer Holdings Corporation, IQVIA Inc., Plexus Corp., Sanmina Corporation, TE Connectivity, and West Pharmaceutical Services Inc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at